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Summary 
Exocytosis of peptides and steroids stored in a dense core vesicular (DCV) form is the final step 
of every secretory pathway, indispensable for the function of nervous, endocrine and immune systems. 
The lack of live imaging techniques capable of direct, label-free visualisation of DCV release makes 
many aspects of the exocytotic process inaccessible to investigation. We describe the application of 
correlative scanning ion conductance and fluorescence confocal microscopy (SICM-FCM) to study the 
exocytosis of individual granules of insulin from the top, non-adherent, surface of pancreatic β-cells. 
Using SICM-FCM, we were first to directly follow the topographical changes associated with 
physiologically-induced release of insulin DCVs. This allowed us to report the kinetics of the full fusion 
of the insulin vesicle as well as the subsequent solubilisation of the released insulin crystal.  
Introduction 
Examples of over 50 biologically active peptides/low molecular-weight substances released by 
exocytosis include body’s only glucose-lowering hormone insulin, adrenaline regulating the ‘flight-or-
fight’ response as well as dopamine, serotonin and large neurotransmitter molecules(Golan et al., 2011). 
Our understanding of secretory (patho)physiology is increasingly based on real-time functional studies, 
a powerful tool that allowed pin-pointing functional defects observed in such diseases as diabetes 
mellitus(Collins et al., 2016). For instance, advances in high resolution fluorescence live imaging, 
particularly super-resolution stimulated emission depletion (STED), allowed real-time visualisation of 
a fusion pore dynamics thereby providing a better understanding of secretion mechanisms(Shin et al., 
2018; Zhao et al., 2016). However, as any nanoscale fluorescent reporter is likely to affect the secretory 
kinetics, every molecular detail of insulin release that we are aware of comes from surrogate 
molecules(Gandasi et al., 2018; Low et al., 2014; Tarasov et al., 2018) or indirect measurements(Hastoy 
et al., 2018; Li et al., 2011). The need for revealing the secretory machinery as it happens in real life 
suggests for less invasive live-imaging techniques capable of direct, label-free visualisation of DCV 
release, which could also be combined with fluorescence imaging.  
Biophysical alternatives to fluorescence microscopy of single-vesicle exocytosis are nominally 
free from the label problem; at the same time, they are less informative than imaging and, again, do not 
measure insulin release directly. Monitoring of single-vesicle exocytosis using patch-clamp 
electrophysiology(Neher & Marty, 1982) or electrochemical techniques(Huang et al., 1995; Zong et al., 
2010) provides excellent signal-to-noise ratio but largely lacks spatial information. This problem may 
be resolved by using scanning probe microscopy (SPM) techniques. Atomic force microscopy (AFM) 
has been applied to imaging of regulated exocytosis in AT2 cells but the prohibitively high forces 
applied by AFM probe keep the resolution of the technique way off the individual DCV range(Hecht et 
al., 2012). Scanning Ion Conductance Microscopy (SICM) has been successfully utilised for the 
detection of the exocytotic sites by the scanning probe in chromaffin cells, fixed before and after the 
stimulation(Shin & Gillis, 2006). 
Our approach, a combination of optical microscopy and SPM techniques, is based on a 
simultaneous acquisition of the label fluorescence and rasterising the ‘surface landscape’ of the cell 
membrane. The fluorescent label has an auxiliary role assisting the selection of the region of interest 
(ROI) for the scanning probe, a glass nanopipette that follows the surface of a sample within the ROI 
very closely albeit without touching. In this way, correlative scanning ion conductance microscopy - 
fluorescence confocal microscopy (SICM-FCM) imaging effectively operates directly and non-
invasively, which makes it a perfect fit for live-cell studies. A recent improvement of the acquisition 
rate has allowed us to monitor secretion of individual insulin containing vesicles in real time. 
Methods 
SICM-FCM 
Principles of operation. SICM generates high-resolution (down to ~5nm) topographical images 
of samples immersed in liquid by raster scanning a glass nanopipette (probe) that follows the surface of 
a sample very closely without touching (Adenle & Fitzgerald, 2005; Hansma et al., 1989; Korchev et 
al., 1997; Shevchuk et al., 2006). Importantly, SICM sets no requirement for any kind of chemical 
processing of the studied sample and effectively operates in native conditions. This fully non-invasive 
aspect of imaging makes SICM ideal for living cell studies. The SICM instrument (Fig. 1A) consists of 
a nanopipette mounted on a Z piezo actuator connected to a scan control unit that performs vertical 
measurements and raster-scanning XY piezo actuator that carries the cell sample in a Petri dish. Control 
electronics measures the ion current that flows between the probing and the reference electrodes located 
inside the SICM pipette and in the bath, respectively. When the pipette approaches the sample surface 
to approximately one radius of its [pipette tip] opening, the ion current drops (Fig. 1B). This drop is 
used by the control software to stop the approach and record the vertical position of Z piezo actuator as 
the sample height at this imaging point. The pipette is then withdrawn, and sample is moved to the next 
location (Fig. 1A, red arrows). Such regime of scanning is termed Hopping Probe SICM 
(HPICM)(Novak et al., 2009).  
Simultaneous fluorescence confocal imaging is performed by a laser beam focused at the pipette 
tip (Gorelik et al., 2002). This provides co-localized fluorescence excitation, which is then recorded by 
a photomultiplier. Confocal auto-focusing is achieved by vertical movement of the objective focusing 
piezo actuator that is synchronised with the SICM height measurement Z piezo actuator. This eliminates 
the need for 3-D reconstruction through numerous confocal slices and allows the fluorescence data to 
be acquired precisely from the apical membrane in single scan (dashed line, Fig. 1A). Figure 1C shows 
an example of a 3-D topographical and matching fluorescence images of an insulin granule releasing at 
the apical surface of an INS-1E cell and corresponding NPY-Venus fluorescence targeted to the 
granules by means of fusion with neuropeptide Y. Like other scanning probe microscopy techniques, 
SICM image generation relies on the scanning of its probe over the sample surface. Since piezo 
actuators used to move the probe have finite time response, the imaging rate depends on the image size 
and the number of pixels comprising the image. It has been demonstrated that it is possible to design 
and construct SICM that could be operated in high speed (HS) regime sufficient to follow highly 
dynamic processes in living cells (Ida et al., 2017; Simeonov & Schäffer, 2019a, 2019b). 
All experiments were performed using a custom built SICM setup consisting of XY-stage (45 x 
45 μm, Direct Drive, Capacitive Sensors, Parallel Metrology, IC-XY-4545-001) and Z-stage (25 μm, 
Direct Metrology, Capacitive Sensor, IC-Z-25-001) powered by Piezo Controller System (IC-PDC-
001) and operated using ICAPPIC Controller (IC-UN-001, ICAPPIC Ltd., UK). To allow high speed 
imaging the setup was equipped with a fast Z piezo actuator (IC-HSZ-001, ICAPPIC Ltd. UK). Fine 
alignment of the scanning nanopipette tip with the laser beam in the XY plane was done using two N-
470 PiezoMike Linear Actuators (Physik Instrumente, Germany) and was based on the optical image 
acquired using a 100× oil immersion objective. Therefore, partial offset of fluorescence images in 
relation to topography could be observed. Images were superimposed by adjusting fluorescence image 
contrast to saturation and tracing the edges of fluorescence spots using ImageJ software 
(https://imagej.nih.gov/ij/). Then the background of fluorescence images was set transparent and the 
images overlaid on corresponding topographical image. 
Nanopipettes were pulled from BF-100-50-7.5 borosilicate glass capillaries (Sutter Instrument 
Co., USA) using a P-2000 laser puller (Sutter Instrument Co., USA). Ion currents were measured using 
an Axopatch 200B amplifier (Molecular Devices, UK) with a gain of 1 mV/pA and a low-pass filter 
setting of 5 kHz. The internal holding voltage source of the Axopatch 200B was used to supply a direct 
current voltage of +200 mV to the pipette. The ion current and outputs of the capacitive sensors from 
all three piezo elements were monitored using Axon Digidata 1322A and Clampex 9.2 (Molecular 
Devices, UK).  
Fluorescence images were recorded using a D-104 Microscope Photometer (Photon Technology 
International, Inc. USA) through a 100×/1.3NA oil immersion objective. The excitation was provided 
by a 488-nm wavelength diode-pumped solid-state laser (Laser 200; Protera) focused to diffraction 
limited spot. Confocal volume height was 1.5 m estimated by imaging of 100nm TetraSpeck 
microspheres (T7279, Life Technologies Corporation, Oregon, USA) in XZ plane. 
SICM-FCM control, data acquisition and analysis were performed using HPICM Scanner and 
SICM Image Viewer software (ICAPPIC Ltd, UK) custom modified by authors.  
Cell culture and plasmids. 
INS1-E cells were cultured in RPMI1640 medium (11 mM glucose) supplemented with 10% of 
fetal bovine serum and 50 μM of β-mercaptoethanol. Cells were cultured under sterile conditions, 37°C, 
100% humidity. Prior to the experiments, INS1 cells or primary β-cells were plated on glass-bottomed 
dishes (MatTek Life Sciences, USA) and NPY-Venus (kindly provided by Atsushi Miyawaki, RIKEN 
BSI, Wako, Japan) was delivered adenovirally, with 24-36-h expression time. 
Animals and islet isolation 
C57Bl/6 mice (Charles River, Harlow, UK) were used throughout the study. Mice were kept in 
a conventional vivarium with a 12-hour-dark/12-hour-light cycle and ad libitum access to food and 
water and were killed by cervical dislocation. All mouse experiments were conducted in accordance 
with the United Kingdom Animals (Scientific Procedures) Act (1986) and the University of Oxford 
ethical guidelines. 
Pancreatic islets were isolated from mice by injecting liberase (Type V, Sigma) solution into the 
bile duct, with subsequent digestion of the connective and exocrine pancreatic tissue. Islets were picked 
using a P20 pipette, under a dissection microscope and cultured overnight in RPMI medium containing 
11mM glucose, supplemented with 10% FBS, 100IU/mL penicillin and 100μg/mL streptomycin (all 
reagents from Life Technologies/ThermoFisher, Paisley, UK). Islets were dispersed into single cells by 
pipetting in low-Ca2+ extracellular medium.  
 
Results 
Morphological changes associated with insulin secretion in INS1-E cells 
We first studied insulin DCV release in the rat insulinoma cell line, INS-1E. SICM topographical 
images of control uninfected INS1-E cells revealed the cell surface decorated with numerous microvilli 
and dorsal ruffles that could be seen as membrane protrusions (Fig. 2A). We then imaged INS1-E cells 
infected with a type 5 human adenovirus delivering a fluorescent label of insulin DCVs, NPY-
Venus(Nagai et al., 2002; Tarasov et al., 2018). NPY is a 36 amino-acid neuropeptide that is known to 
be packaged into insulin containing granules and is widely used as an insulin secretion marker. SICM-
FCM images of non-stimulated cells revealed similar microvillar and dorsal ruffle structures (Fig. 2B, 
black and white arrows). Superimposing fluorescence and topographical images (see Methods) revealed 
smooth membrane bulges spatially correlating with NPY-Venus fluorescence spots, which could be 
interpreted as membrane-docked insulin-containing vesicles (Fig. 2B, red arrows). The depth of the 
confocal volume (~1.5 m) allows detecting the NPY-Venus fluorescence signal from not yet docked 
insulin vesicles located beneath the membrane. This explains why the majority of fluorescent spots did 
not co-localise with protruding membrane structures, in non-stimulated cells.  
To estimate the density and frequency of the fusion events, we imaged INS1-E cells expressing 
NPY-Venus fixed 10 and 30 seconds after stimulation with 17 mM glucose and 0.2 mM tolbutamide 
(Fig. 3A and B, respectively). Numerous hemispherical protrusions with diameters ranging from 200 to 
400 nm were detectable, 10 s after stimulation  (Fig. 3A),. While some protrusions matched NPY-Venus 
fluorescence (red arrow), representing vesicles fixed at the early stage of release, several protrusions 
without any associated fluorescence signal (cyan arrow) were also seen. 
SICM-FCM images of cells fixed 30 seconds after the stimulation show larger numbers of insulin 
granules on the cell membrane and fewer NPY-Venus fluorescence maxima (Fig. 3B), as compared to 
cells fixed 10 seconds after stimulation (Fig. 3A). Yet, we still were able to detect several fluorescent 
spots correlating with protrusions (red arrow in Fig. 3B). A typical protrusion had linear size of 200-
400 nm and ~500 nm height (Fig. 3C, representing the zoomed red box in Fig. 3B). The distribution of 
protrusion size measured by SICM had the mean diameter of 0.28±0.06m (n=71) (Fig. 3D), in 
reasonable agreement with values for insulin crystals of 150-200 nm, estimated by TEM (Raleigh et al., 
2017). We therefore conclude that, correlative SICM-FCM imaging can identify and topographically 
resolve individual insulin granules on the cell membrane of the INS1E cells.  
 
Kinetics of insulin dense core vesicle release in INS-1E cells 
To resolve the kinetics of DCV fusion and subsequent insulin granule release, we performed 
correlative time-lapse SICM-FCM imaging of stimulated INS1-E cells (Fig. 4). We observed a NPY-
Venus fluorescence maxima marking a spot of subsequent topographically detected protrusion 
corresponding to released insulin granules (Fig. 4A, first frame, labelled ’00:00’). This corresponds to 
the docking of the insulin-loaded vesicle to the cytoplasmic side of the cell membrane(Whim, 2011). A 
rapid appearance of a protrusion at the spot (cyan arrow) is likely to reflect the vesicle fusion and 
exposure of the insulin granule on the cell surface (Fig. 4A, 3rd frame, ’00:36’, indicated by red arrow). 
From this moment, both the size of the protrusion and the intensity of NPY-Venus fluorescence begin 
to drop, suggesting the dissolution of the insulin crystal (Fig. 4B, frames 4-7, ’00:54’ onwards). We 
also observed events in which protrusions that correlated spatially with NPY-Venus fluorescence spot 
appeared only in one frame. These could represent insulin granules that detach from the cell membrane. 
The average granule release/dissolution time measured from the moment of its appearance on the cell 
membrane to complete disappearance was 40±21 sec. (n=7). Reported by light microscopy, the diameter 
of 20-μm synthetic insulin crystals reaches the limit of detection (~200 nm, corresponding to a 100-fold 
decrease in the linear size) between 210 and 440 seconds, depending on the presence/absence of 
albumin in the solvent (Lougheed et al., 1981). Likewise, we earlier reported a several minute-long 
delay between the peak post-secretory endocytosis and bulk insulin levels in the extracellular medium 
(Tarasov et al., 2018). A tenfold decrease of the protrusion diameter, from ~300 nm (Fig. 3A) down to 
30 nm, a small size particle that could be resolved with confidence by SICM on a surface of living cell, 
fits very well within this range.  
A possible cause for the delay between the dissipation of the NPY-Venus fluorescence and the 
protrusion reported at the putative site of exocytosis is the difference in kinetics of the dissolution of 
the crystal and diffusion of a small protein off the cell surface. Differently from the inverted TIRF 
imaging, both freshly released NPY-Venus and insulin crystal are facing a much larger volume of the 
medium, hence both processes are likely to proceed faster, on the top, unrestricted surfaces of cells.  
On several occasions, we were able to detect an indentation in the cell membrane that preceded 
the arrival of the NPY-labelled insulin granule to the cell membrane (Fig. 5A, red arrow, third frame at 
36 seconds). Based on the spatial and temporal correlation of topographically detected insulin granule 
and NPY-Venus fluorescence spot we conclude the indentation represents the full opening of the fusion 
pore, perhaps reflecting the final stages of full fusion of the insulin vesicle with the plasma membrane. 
The pore opening was 370 nm measured as full width at half minimum that is in agreement with recently 
published STED observations (Shin et al., 2018). 
Insulin dense core vesicle release in primary β-cells 
We then applied the imaging technology to primary mouse pancreatic islets and imaged the 
secretion of unlabelled insulin granules in primary mouse β-cells, with the stimulation being provided 
locally via a micropipette (Fig. 6A). The stimulation resulted in drastic cell surface changes that could 
be observed in SICM topographical images (Fig. 6 B). Similar to what we observed in INS1 cells, the 
protrusions resembling insulin granules by size and shape, within several minutes after the stimulation 
of β-cells (Fig. 6C). The average release and dissolution time of putative insulin granules in -cells was 
52±25 sec (n=3), close to that observed for INS1-E cells. 
 
Discussion 
Although hormone DCV release was studied in detail using fluorescence live imaging of 
associated reporter molecules, little is known about the secretion and dissolution kinetics of individual 
granules of insulin itself. Insulin is densely packed within the β-cell DCV, with the reported 
concentrations  of 118 and 74 mM for human and rat β-cells, respectively(Rorsman & Renström, 2003). 
The peptide has been shown to exist in a form of heterohexamer (MW=36 kDa, Rh=5.5-5.6 nm(Hvidt, 
1991; Oliva et al., 2000)) at concentrations exceeding 2 mM(Hansen, 1991). Insulin is therefore likely 
to be stored within the vesicles predominantly as a crystallised hexamer(Brange & Langkjœr, 1993), 
possibly accompanied by a small soluble fraction. The latter point has been long supported by the 
electron microscopy (EM) of chemically fixed cells reporting insulin secretory granules (ISG) as 200-
mn electron–dense cores, surrounded by a 100nm lighter halo, both encapsulated within a lipid 
membrane(Dean, 1973; Sorra et al., 2006). The authenticity of the halo, conventionally believed to 
contain soluble insulin, was, however, recently been questioned: the halo was not found in high-pressure 
frozen preparations and therefore was referred as a chemical fixation artefact(Fava et al., 2012). A 
similar halo was reported in chromaffin cells, with the ability to detect the halo depending on the 
fixation method(Stevens et al., 2011).  
Based on monitoring of fluorescent insulin surrogates (typically, GFP variants fused to DCV 
membrane proteins or cargo molecules)(Tsuboi & Rutter, 2003) or Zn2+ (Li et al., 2011; Michael et al., 
2006; Qian et al., 2003) (an ion that stabilises insulin hexamer, can be visualised with a number of 
specific dyes) using total internal reflection fluorescence (TIRF) microscopy, two distinct modalities 
have been suggested for the insulin vesicle exocytosis. The release of insulin via a transient fusion pore, 
via the so-called ‘kiss-an-run’ process avoiding the full fusion of the vesicle and liberation of its non-
soluble contents, was suggested based on monitoring NPY-Venus kinetics(Tsuboi & Rutter, 2003). The 
full fusion was believed to represent a relatively slower (1-2s) and irreversible event resulting in the 
dissolution of the insulin crystal in extracellular milieu(Michael et al., 2006). 
The weakness of these fluorescence measurements is that the size of the reporter is different to 
that of insulin and so is likely to be its kinetics. The fluorescent tag (YFP) fused to vesicular cargo 
(NPY) is a protein with molecular weight over 26.9 kDa, and Rh of 2.2 nm (Hink et al., 2000) i.e. less 
than a half of the radius of the vesicular hexameric insulin (5.6 nm(Hvidt, 1991)), perhaps more capable 
of reflecting the dynamics of insulin monomers or dimers (2.7 and 3.8 nm, respectively(Oliva et al., 
2000)).  
The observed release kinetics of the chimaeric construct might therefore represent that of the tag 
rather than the cargo protein itself (Michael et al., 2006), which becomes critical, when considering the 
ability to pass through the fusion pore of a size of 1.4-1.6 nm(Kasai et al., 2010; MacDonald et al., 
2006). Thus, the true ability of hexameric insulin to leave through the fusion pore remains questionable. 
Complicating matters, in technical sense, TIRF microscopy does not report fusion of vesicles with 
extracellular medium; instead it monitors vesicles fusing with a small confined 30-50nm space between 
the glass and the cell membrane. This is highly likely to affect the rate of a 250-nm (Hink et al., 2000) 
crystalline insulin core release and dissolution as the volume-limited diffusion certainly enhances the 
observed spatial and temporal correlation between insulin and fluorescent markers. 
In our hands, the released insulin granule had a measurable lifetime of 40±21 s at the cell 
membrane, correlating well with earlier observations of insulin crystal dissolution (Lougheed et al., 
1981) as well as high-content imaging of endocytosis in islets (Tarasov et al., 2018). This finding can 
also explain a ~2-min delay between the depolarisation-induced influx of Ca2+ and insulin secreted by 
pancreatic islets and detected in a soluble form in the bath medium (Ravier et al., 1999). 
 
Conclusion 
Here we show that high speed correlative SICM-FCM can be used to visualise both unlabelled 
insulin granule and fluorescently labelled insulin DCV release from the top, non-adherent surface of 
primary pancreatic β-cells as well as β-cell lines, such as INS1-E cells. These results establish 
correlative SICM-FCS as a method of choice for studying the molecular mechanisms of diabetes 
induced by impaired or deficient hormone secretion from pancreatic islet cells as well as profiling novel 
drugs targeting pancreatic hormone release.  
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Figure legends 
 
Fig. 1. SICM-FCM principles of operation. (A) Schematic diagram of simultaneous, 
correlative scanning ion conductance and fluorescence confocal microscope. (B) Vertical position (Z) 
and corresponding ion current (Ipip) traces during two adjacent points measurement. (C) SICM 
topography and confocal image pair shows insulin granule on the INS-1E cell plasma membrane and 
corresponding NPY-Venus fluorescence. 
 
Fig. 2. INS1-E cell surface morphology. (A) Typical SICM topographical image of control 
(uninfected) INS1-E cell showing microvilli (black arrow) and dorsal ruffles (white arrow). (B) 
Correlative SICM (left panel), fluorescence confocal (middle panel) and overlay (right panel) images 
of non-stimulated INS1-E cell expressing NPY-Venus fixed on ice showing microvilli (black arrow), 
dorsal ruffles (white arrow) and membrane-docked insulin DCVs (red arrows). 
 
Fig. 3. Correlative SICM-FCM images of insulin granules on surfaces of stimulated INS1-
E cells expressing NPY-Venus. (A) Images of INS1-E cell fixed 10 seconds after stimulation showing 
released insulin granules with (red arrow) and without (cyan arrow) associated NPY-Venus 
fluorescence. (B) Images of INS1-E cells fixed 30 seconds after stimulation showing released insulin 
granules. Few granules have associated NPY-Venus fluorescence (red arrow). (C) Cross section profile 
and zoomed 3D topographical image (inset) of typical released insulin granule boxed in (B). (D) 
Distribution of insulin granule diameters measured by SICM. 
 
 
Fig. 4. Insulin DCV secretion in INS1-E cells expressing NPY-Venus. (A) Topographical (top 
row) and NPY-Venus fluorescence (bottom row) time lapse images showing appearance of insulin 
granule on the cell surface (red arrow at 00:36 seconds) and corresponding NPY-Venus fluorescence 
signal (cyan arrow) recorded ~2 min after stimulation. (B) Cross section profiles of SICM topography 
(black trace) and fluorescence intensity (green trace) for each frame at location marked with white 
dashed line in the first frame (A). 
 
Fig. 5. Opening of the fusion pore during complete fusion. (A) Topographical (top row) and 
NPY-Venus fluorescence (bottom row) time lapse images showing the opening of the fusion pore (red 
arrow at 00:36 seconds) followed by the appearance of insulin granule on the cell surface (red arrow at 
00:54 seconds), and corresponding NPY-Venus fluorescence signal (cyan arrow) recorded ~2 min after 
stimulation. (B) Cross section profiles of SICM topography (black trace) and fluorescence intensity 
(green trace) for each frame at location marked with white dashed line in the first frame (A). 
 
Fig. 6. Insulin DCV secretion in primary b-cells. (A) Bright filed images of a -cell (white 
arrow) before (top panel) and after (bottom panel) localised stimulation through micropipette (black 
arrow). (B) SICM topographical images of a -cell before (top) and after (bottom) stimulation. (C) 
Series of SICM topographical time lapse images showing the release and dissolution of insulin granule 
(red arrow) recorded ~4 min after stimulation. 
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